Abstract
Immunodeficiency with normal or increased immunoglobulin (Ig)M (HIGMX-1) was discovered by Rosen et al. (1961), when one of the original five patients with what was thought to be X-linked agammaglobulinemia (XLA) appeared at the Boston Children’s Hospital at age 16 years with a diagnosis of acute poststreptococcal glomerulonephritis. When an attempt was made to measure the CH50 in his fresh serum, an unexpected finding supervened. Instead of the CH50 being markedly decreased, as would be anticipated in acute potstreptococcal glomerulonephritis, it was found to be so elevated that an endpoint could not be reached in the hemolytic titration. It was reasoned that this might be due to the presence of Forssman antibodies to sheep red blood cells used to measure the CH50, and this indeed turned out to be the case. It was known then that Forssman antibody, like other antibodies to lipopolysaccharides, were macroglobulins and the serum of this patient was found to have other macroglobulin antibodies in high titer. His serum was analyzed in a Model E ultracentrifuge and found to have an increased 19S peak and no 7S peak. Immunoelectrophoretic patterns revealed the presence of a prominently increased IgM band, very little IgG, and no IgA. Soon thereafter, another male child with chronic purulent sinusitis and bronchiectasis was admitted to the Boston Children’s Hospital. His total serum immunoglobulins were found to be about 230 mg/dl. When his serum was subjected to analytical ultracentrifugation, an increased 19S peak was found and the 7S peak was barely discernible. These two similar cases were reported together (Rosen et al. 1961). Shortly thereafter, another male with an identical immunological abnormality was reported in the French literature (Burtin 1961). Over 100 cases have been reported in the world literature, and these reports have recently been reviewed by Notarangelo et al. (1992). The disease is most commonly inherited as an X-linked phenomenon, but similar cases that appear to have autosomal recessive inheritance have been described, as well as sporadic cases, particularly following the rubella pandemic 3 decades ago. This discussion is confined to the X-linked form of the disease, because the genetic defect in HIGMX-1 has recently been established to be a defect in the T cell ligand for CD40.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allen RC, Armitage RJ, Conley ME, Rosenblatt H, Jenkins NA; Copeland NG, Bedell MA, Edelhoff S, Disteche CM, Simoneaux DK, Fanslow WC, Belmont J, Spriggs MK (1993) CD40 ligand defects responsible for X-linked hyper-IgM syndrome. Science 259: 990–993
Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, Bajorath J, Grosmaire LS, Stenkamp R, Neubauer M, Roberts RL, Noelle RJ, Ledbetter JA, Francke U, Ochs HD (1993) The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72: 291–300
Burtin P (1961) Un exemple d’agammaglobulinemie atypique (un cas de grande hypogam-maglobulinemie avec augmentation de la ß2-macroglobuline). Rev Fr Etud CHn Biol 6: 286–289
DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint Basile G (1993) CD40 ligand mutations in X–linked immunodeficiency with hyper–IgM. Nature 361: 541–543
Fuleihan R, Ramesh N, Loh R, Jabara H, Rosen FS, Chatila T, Fu SM, Stamenkovic I, Geha RS (1993) Defective expression of the CD40 ligand in X chromosome–linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sei USA 90: 2170–2173
Geha RS, Hyslop N, Alami S, Farah F, Schneeberger EE, Rosen FS (1979) Hyper immunoglobulin M immunodeficiency (dysgammaglobulinemia). J Clin Invest 64: 385–391
Goodship J, fCallard R, Malcolm S, Levinsky RJ (1991) Investigation of X chromosome use in an obligate carrier of hyper IgM syndrome. In: Chapel HM, Levinsky RJ, Webster ADB (eds) Progress in immune deficiency III. Royal Society of Medicine, London, p 273
Graf D, Korthauer U, Mages HW, Senger G, Kroczek RA (1992) Cloning of TRAP, a ligand for CD40 on human T cells. Eur J Immunol 22: 3191–3194
Hendriks RW, Kraakman MEM, Craig IW, EspanolT, Schuurman RKB (1990) Evidence that in X–linked immunodeficiency with hyperimmunoglobulinemia M the intrinsic immunoglobulin heavy chain class switch mechanism is intact. Eur J Immunol 20: 2603–2608
Hendriks RW, Sandkuyl LA, Kraakman MEM, EspanolT, Schuurman RKB (1991) RFLP linkage and X chromosome inactivation analysis in X–linked immunodeficiency with hyperimmunoglobulinemia M. In: Chapel HM, Levinsky RJ, Webster ADB (eds) Progress in immune deficiency III. Royal Society of Medicine, London, pp 266–271
Hollenbaugh D, Grosmaire LS, Kullas CD, Chalupny NJ, Stamenkovic I, Ledbetter JA, Aruffo A (1992) The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 11: 4313–4321
Korthauer U, Graf D, Mages HW, Briere F, Padayachee M, Malcolm S, Ugazio AG, No-tarangelo LD, Levinsky RJ, Kroczek RA (1993) Defective expression of T–cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361: 539–541
Levitt D, Haver P, Rich K, Cooper MD (1983) Hyper IgM immunodeficiency. A primary dysfunction of B lymphocyte isotype switching. J Clin Invest 72: 1650–1657
Mayer L, Kwan SP, Thompson C, Rosen F (1986) Correction of a defect in immunoglobulin class switching in patients with immunodeficiency and hyper-IgM by “switch” T cells. In: Eibl MM, Rosen FS (eds) Primary immunodeficiency diseases. Elsevier, Amsterdam, pp 181–186
Mensinck EJBM, Thompson A, Sandkuyl LA, Kraakman MEM, Schot JDL, Espanol T, Schuurman RKB (1987) X-linked immunodeficiency with hyperimmunoglobulinemia M appears to be linked to the DXS42 restriction fragment length polymorphism locus. Hum Genet 76: 96–99
Notarangelo LD, Duse M, Ugazio AG (1992) Immunodeficiency with hyper-IgM ( HIM ). Immunodefic Rev 3: 101–122
Padayachee M, Feighery C, Finn A, McKeown C, Levinsky RJ, Kinnon C, Malcolm S (1992) Mapping of the X–linked form of hyper-IgM syndrome (HIGM1) to Xq26 by close linkage to HPRT. Genomics 14: 551–553
Ramesh N, Fuleihan R, Ramesh V, Lederman S, Yellin MJ, Sharma S, Chess L, Rosen FS, Geha RS (1993) Deletions in the ligand for CD40 in X–linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1). Int Immunol 5: 769–773
Rosen FS, Kevy SV, Merler E, Janeway CA, Gitlin G (1961) Recurrent bacterial infections and dysgammaglobulinemia: deficiency of 7S gammaglobulins in the presence of elevated 19S gammaglobulins. Pediatrics 28: 182–195
Rowe DS, Fahey J (1965) A new class of human immunoglobulins: normal serum IgD. J Exp Med 121: 185–199
Schwaber JF, Lazarus H, Rosen FS (1981) IgM-restricted production of immunoglobulin by lymphoid cell lines from patients with immunodeficiency with hyper IgM (dysgammaglobulinemia). Clin Immunol Immunopathol 19: 91–97
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Rosen, F.S. (1994). Immunodeficieny with Normal or Increased Immunoglobulin M. In: Eibl, M.M., Huber, C., Peter, H.H., Wahn, U. (eds) Symposium in Immunology III. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78438-5_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-78438-5_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-57126-1
Online ISBN: 978-3-642-78438-5
eBook Packages: Springer Book Archive